摘要
阿尔茨海默病(AD)的发病机制包括异常错折叠蛋白、淀粉样蛋白(Aβprotein,Aβ)和τ蛋白的沉积。β包括老年性斑块和形成神经原纤维缠结的τ聚集体,两者都是AD的标志。自噬是细胞内聚集蛋白A、β和功能失调的主要保守途径。许多动物模型研究表明,自噬通常是对抗AD进展的保护因子,与细胞质内毒性A、β和τ聚集有关。自噬的上调也有利于AD的治疗。改善对调节自噬的信号通路的理解对于发展AD治疗至关重要。本文综述了自噬的细胞和分子机制、它们在AD发病机制中的作用以及目前的药物发现策略。
关键词: 阿尔茨海默病,自噬,τ,淀粉样β蛋白,自噬体,治疗。
Current Alzheimer Research
Title:The Implications of Autophagy in Alzheimer’s Disease
Volume: 15 Issue: 14
关键词: 阿尔茨海默病,自噬,τ,淀粉样β蛋白,自噬体,治疗。
摘要: The pathogenic mechanisms of Alzheimer’s Disease (AD) involve the deposition of abnormally misfolded proteins, amyloid β protein (Aβ) and tau protein. Aβ comprises senile plaques, and tau aggregates form Neurofibrillary Tangles (NFTs), both of which are hallmarks of AD. Autophagy is the main conserved pathway for the degeneration of aggregated proteins, Aβ, tau and dysfunctional organelles in the cell. Many animal model studies have demonstrated that autophagy normally functions as the protective factor against AD progression associated with intracytoplasmic toxic Aβ and tau aggregates. The upregulation of autophagy can also be favorable in AD treatment. An improved understanding of the signaling pathways that regulate autophagy is critical to developing AD treatments. The cellular and molecular machineries of autophagy, their function in the pathogenesis of AD, and current drug discovery strategies will be discussed in this review.
Export Options
About this article
Cite this article as:
The Implications of Autophagy in Alzheimer’s Disease, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666181004143432
DOI https://dx.doi.org/10.2174/1567205015666181004143432 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Challenges for ACE-Inhibitors in Vascular Diseases
Drug Design Reviews - Online (Discontinued) Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews Recent Patents, Formulation and Characterization of Nanoliposomes
Recent Patents on Drug Delivery & Formulation New Approaches for the Treatment of Mental Disorders Comorbid with Inflammatory Diseases
Current Topics in Medicinal Chemistry Reduction in Vascular Endothelial Growth Factor Expression in the Superior Temporal, Hippocampal, and Brainstem Regions in Alzheimer`s Disease
Current Neurovascular Research Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets 1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation Magnetic Resonance Imaging of Iron in Parkinsons Disease
Current Medical Imaging Neuroprotective Therapy for HIV Dementia
Current HIV Research Molecular Markers of Cardiovascular Damage in Hypertension
Current Pharmaceutical Design Tau as a Molecular Marker of Development, Aging and Neurodegenerative Disorders
Current Aging Science Development of Effective Therapeutics Targeting the GABAA Receptor: Naturally Occurring Alternatives
Current Pharmaceutical Design Calcium Signalling Toolkits in Astrocytes and Spatio-Temporal Progression of Alzheimer's Disease
Current Alzheimer Research Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets
Current Protein & Peptide Science A Clinician’s Guide to Monoamine Oxidase Inhibitors
Current Psychiatry Reviews Patent Review on Network-based Elderly Healthcare System in the US
Recent Patents on Computer Science Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry Editorial [Hot topic: Tau, Neurodegeneration and Alzheimers Disease (Guest Editor: Alejandra del Carmen Alonso)]
Current Alzheimer Research